Consistently, administration of Magnolol, an autophagy regulator compound, to transgenic mice model of AD inhibited apoptosis and decreased AD‐related pathologies by activating the AMPK/mTOR/ULK1 pathway.116. This evidence concerns the gene MTOR and Alzheimer disease.